





























































































































































































































































































































































































































































































































































































































































































































































Study'type' Treatment'Group' Control' Fatigue'scales' Main'finding'
Minderhoud'
(2007)[15]'





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































! Total! CD! UC! pCvalue!between!
CD!and!UC!
Number!enrolled! 113! 70! 43! !













































CDAI/SCAI! ! Mean!=!110!(SD=17.5)! Mean!=!4.74!(SD=2.6)! !
Ferritin! Mean!=!105!(SD=104)! Mean!=!105!(SD=109)! Mean!=!105!(SD=98.1)! 0.9691!
CRP! Mean!=!4.2!(SD=5.6)! Mean!=!5.2!(SD=6.7)! Mean!=!2.5!(SD=2.3)! 0.0191!
Faecal!
calprotectin!
































Total! Active! Remission! Total! Active! Remission! Total! Active! Remission!






















































































































































** 0.06 -0.19* 4.4/5.2 5.0/4.7 5.1/4.9 5.1/4.8 5.7/3.7 





* 0.05 -0.12 12.2/14.5 13.8/13.2 14.6/13.3 13.6/13.6 14.7/11.9 




Coefficient/Mean 0.00 0.10 -0.06 10.8/13.3 12.6/11.8 13.1/12.1 11.8/12.6 13.1/11.0 




Coefficient/Mean -0.05 0.06 -0.06 9.9/11.7 11.4/10.4 12.0/10.8 10.5/11.3 11.9/9.6 




Coefficient/Mean -0.09 -0.02 -0.01 9.5/10.5 10.2/10.0 11.1/9.9 9.7/10.4 11.1/8.7 





** 0.03 -0.19* 10.3/11.0 11.1/10.1 11.0/10.6 9.6/11.4 11.2/10.1 





































































-0.21 0.07 -0.22 4.7/5.4 55.8/5.0 5.8/4.8 6.5/4.4 






-0.17 0.08 -0.28* 12.9/14.4 14.9/13.5 14.2/13.6 15.2/13.0 






0.02 0.06 -0.11 11.4/13.3 13.6/12.3 12.1/12.8 13.4/12.1 






-0.06 -0.04 -0.09 10.9/11.7 12.8/11.0 11.0/11.5 12.5/10.7 






-0.09 -0.06 -0.13 10.0/10.4 10.9/10.1 10.2/10.3 11.7/9.3 






-0.21 -0.03 -0.29* 10.7/11.4 10.8/11.2 10.3/11.5 12.8/10.1 





























-0.28 0.04 -0.09 4.0/5.2 4.9/4.7 4.7/4.7 5.4/3.9 






-0.29 0.01 0.15 11.2/14.6 14.1/13.0 12.9/13.5 14.7/11.4 






0.04 0.18 0.02 9.7/13.2 12.3/11.7 11.5/12.1 12.8/10.7 






0.02 0.24 0.00 8.5/11.7 10.7/10.4 9.7/10.9 11.1/9.5 






-0.09 0.05 0.17 8.82/10.7 11.4/9.6 9.2/10.6 10.4/9.4 






-0.24 0.13 0.00 9.6/10.5 11.3/9.8 8.5/11.3 10.2/10.1 







































Exercise score 1 Physical activity levels (H/M/L) 2 




Coefficient/Mean 0.02 0.08 -0.01 5.1/4.7/5.0 5.9/4.5/5.6 4.4/5.2/4.3 




Coefficient/Mean -0.12 -0.11 -0.10 12.8/14.0/13.9 13.4/13.7/14.8 11.7/14.7/12.9 




Coefficient/Mean -0.18 -0.10 -0.28 11.5/12.1/13.7 12.4/12.1/14.1 10.1/12.1/13.2 





** -0.12 -0.42** 9.8/10.8/12.9 10.9/10.8/13.5 8.15/10.8/12.2 





* -0.18 -0.23 9.2/10.1/11.4 9.4/9.9/12.2 8.8/10.4/10.5 





* -0.26 9.2/11.4/11.3 9.2/11.4/11.3 8.0/11.1/10.9 
p-value 0.073 0.046 0.104 5.1/4.7/5.0 0.052 0.150 
 H=High physical activity 
M=Moderate physical activity 































































Spearman’s rho test 
Ferritin (u/L) CRP Faecal calprotectin 




Coefficient -0.14 -0.12 -0.21 0.12 0.12 0.12 0.25
** 0.26* 0.18 




Coefficient -0.06 0.00 -0.15 0.05 -0.01 0.12 0.16 0.09 0.29 




Coefficient -0.01 0.00 -0.03 0.07 0.06 0.02 0.10 0.13 0.09 




Coefficient -0.05 -0.03 -0.11 0.10 0.11 0.03 0.21
* 0.33** 0.02 




Coefficient -0.09 -0.06 -0.13 0.06 0.14 -0.10 0.18 0.23 0.10 




Coefficient -0.05 0.03 -0.18 0.01 -0.07 0.07 0.09 0.13 0.07 





























! IBD! CD! UC! pLvalue!
between!CD!
and!UC!
Number!enrolled! 68! 49!(72%)! 19!(28%)! !





































Mean!=!16.7!(SD=12.6)! Mean!=!15.7!(SD=11.3)! Mean!=!19.2!(SD=15.7)! 0.7561!
CDAI/SCAI! ! Mean!=!126.2!(SD=72.7)! Mean!=!6.6!(SD=2.4)! !
Ferritin! Mean!=!98.4!(SD=93.1)! Mean!=!90.6!(SD=82.4)! Mean!=!118!(SD=116.5)! 0.3741!
CRP! Mean!=!5.8!(SD=6.6)! Mean!=!6.7!(SD=7.4)! Mean!=!3.4!(SD=2.9)! 0.0481!
Faecal!
calprotectin!



























































Coefficient/Mean -0.16 0.16 -0.38
** 5.3/6.0 5.7/5.7 5.6/5.8 5.9/5.6 




Coefficient/Mean -0.15 0.13 -0.28
* 13.5/15.5 14.3/15.8 14.7/14.7 15.4/14.4 




Coefficient/Mean -0.03 0.10 -0.27
* 11.9/13.9 12.6/13.8 13.1/13.2 14.4/12.5 




Coefficient/Mean -0.01 0.14 -0.25
* 11.4/12.3 12.0/11.8 12.1/11.9 12.7/11.6 




Coefficient/Mean -0.03 -0.05 -0.06 10.8/11.3 11.0/11.3 11.4/12.0 11.7/10.7 





* 0.16 -0.14 10.8/11.4 11.4/10.4 10.6/11.3 10.6/11.4 


























Coefficient/Mean -0.12 0.13 -0.37
** 5.2/6.1 6.0/5.7 6.0/5.5 




Coefficient/Mean -0.12 0.14 -0.34
* 13.3/15.0 14.8/14.2 14.9/13.9 




Coefficient/Mean -0.10 0.09 -0.31
* 11.8/13.8 13.1/12.8 12.6/12.9 




Coefficient/Mean -0.04 -0.01 -0.32
* 11.5/12.4 12.8/11.8 11.8/12.0 




Coefficient/Mean -0.04 -0.11 -0.24 10.5/11.3 11.2/10.9 10.9/11.0 




Coefficient/Mean -0.16 0.08 -0.27 10.8/11.9 10.8/11.6 10.1/12.1 



















Coefficient/Mean -0.22 0.34 -0.32 5.9/5.7 4.9/6.1 6.1/5.4 




Coefficient/Mean -0.27 0.17 -0.11 14.4/16.2 14.6/16.2 15.6/16.0 




Coefficient/Mean 0.14 0.31 -0.19 12.2/14.4 13.0/14.1 13.6/14.1 





* 0.00 11.0/12.1 10.8/12.2 11.9/11.8 




Coefficient/Mean 0.02 0.24 0.48
* 11.8/11.1 11.8/11.1 10.8/11.8 




Coefficient/Mean -0.41 0.35 0.31 11.0/10.2 10.4/10.4 9.3/11.4 










































  Exercise score 
1 Physical activity levels (H/M/L) 2 




Coefficient/Mean -0.04 0.03 -0.18 5.6/5.6/6.1 5.2/5.5/6.1 5.3/6.2/6.0 




Coefficient/Mean -0.08 -0.01 -0.31 14.0/15.0/15.2 13.4/14.4/14.8 14.4/17.8/16.0 




Coefficient/Mean -0.12 0.01 -0.39 12.5/12.8/14.7 12.2/12.5/14.1 12.5/13.8/15.7 




Coefficient/Mean -0.20 -0.02 -0.55
* 10.8/11.7/13.9 11.1/11.6/13.6 9.7/12.2/14.3 




Coefficient/Mean -0.19 -0.15 -0.32 10.4/10.6/12.9 10.1/10.7/12.9 10.9/10.2/12.8 




Coefficient/Mean -0.08 0.00 -0.20 10.2/11.9/11.3 10.1/12.0/11.2 9.1/11.2/11.5 
p-value 0.502 0.976 0.403 0.425 0.278 0.773 
  
H=High physical activity 
M=Moderate physical activity 


























p-value 0.041 0.427 
MFI PF 
Correlation 
Coefficient 0.19 0.35 
p-value 0.196 0.155 
MFI RA 
Correlation 
Coefficient 0.22 0.45 





p-value 0.039 0.822 
MFI MF 
Correlation 
Coefficient 0.28 0.11 
















Spearman’s rho test 
Ferritin (u/L) CRP Faecal calprotectin 




Coefficient 0.03 0.06 -0.03 -0.08 -0.12 0.03 -0.16 -0.07 -0.33 




Coefficient 0.08 0.07 0.10 -0.09 -0.03 -0.12 -0.13 -0.10 -0.35 




Coefficient 0.09 0.01 0.24 0.00 0.07 -0.17 -0.07 0.02 -0.28 




Coefficient 0.04 0.07 0.02 0.04 0.08 -0.10 0.05 0.20 -0.38 




Coefficient -0.01 -0.02 0.06 -0.02 0.01 -0.08 0.02 0.04 -0.07 




Coefficient -0.06 -0.02 -0.15 0.01 -0.12 0.18 -0.04 0.02 -0.12 




















45! 21! 242! !




















































CRP! Mean!=!1.8!(SD=1.4)! Mean!=!1.6!(SD=1.4)! Mean!=!1.7!(SD=1.3)! 0.7491!
Faecal!
calprotectin!


























































Coefficient/Mean -0.29 -0.08 -0.18 3.1/4.1 3.5/3.9 4.4/3.5 3.4/3.8 




Coefficient/Mean -0.27 -0.05 -0.14 10.4/12.9 11.2/12.7 14.4/11.3 11.0/12.3 




Coefficient/Mean 0.14 0.14 0.07 9.2/12.3 12.0/10.3 13.1/10.5 9.9/11.6 




Coefficient/Mean -0.01 0.01 -0.02 7.8/10.7 9.9/9.3 11.8/9.0 8.1/10.3 




Coefficient/Mean -0.13 0.05 -0.19 7.7/9.4 8.5/8.9 10.7/8.2 7.7/9.2 




Coefficient/Mean -0.23 -0.20 -0.37
* 10.5/9.4 10.3/9.9 11.6/9.7 9.0/10.6 





























Coefficient/Mean -0.24 -0.11 -0.27 2.9/3.7 3.9/3.3 3.8/3.3 




Coefficient/Mean -0.26 -0.16 -0.30 11.5/13.1 15.2/11.9 12.2/12.9 




Coefficient/Mean 0.31 -0.02 0.29 10.2/12.7 14.4/11.2 10.5/12.5 




Coefficient/Mean -0.10 -0.20 0.22 8.7/10.4 12.8/9.0 8.7/10.4 




Coefficient/Mean -0.23 0.10 -0.20 8.0/8.7 10.4/7.9 8.0/8.7 




Coefficient/Mean -0.24 -0.40 -0.43 10.3/10.3 10.8/10.1 11.0/10.0 



































Coefficient/Mean -0.33 -0.13 -0.15 3.2/4.6 4.9/3.7 3.2/4.3 




Coefficient/Mean -0.24 0.04 0.02 9.8/12.6 13.5/10.8 10.2/11.8 




Coefficient/Mean 0.05 0.32 -0.15 8.7/11.8 11.5/10.0 9.4/10.7 




Coefficient/Mean 0.10 0.17 -0.20 7.4/11.2 10.5/9.1 7.7/10.3 




Coefficient/Mean -0.05 0.01 -0.19 7.6/10.3 11.0/8.5 7.6/9.7 




Coefficient/Mean -0.19 -0.03 -0.30 9.0/10.8 12.5/9.4 7.7/11.2 





























  Exercise score 
1 Physical activity levels (H/M/L) 2 




Coefficient/Mean 0.06 0.14 0.06 4.3/3.5/3.1 5.2/2.3/3.5 3.1/4.8/2.8 




Coefficient/Mean -0.25 -0.35 -0.16 10.4/12.8/11.6 12.6/12.2/14.7 7.4/13.3/10.3 





* -0.31 -0.41* 9.8/11.3/12.1 12.3/11.1/14.3 6.2/11.4/11.1 







* 8.0/9.7/11.2 9.7/9.2/13 5.6/10.7/10.4 




Coefficient/Mean -0.24 -0.25 -0.20 7.0/9.5/8.9 8.0/9.7/8.5 5.6/10.5/8.6 





* -0.47* -0.30 7.4/10.9/11.4 823/10.6/13.7 6.2/11.1/10.4 
p-value 0.020 0.033 0.154 0.425 0.072 0.098 
  
H=High physical activity 
M=Moderate physical activity 





















































p-value 0.106 0.006 
MFI RA 
Correlation 
Coefficient 0.35 0.24 
p-value 0.160 0.265 
MFI RM 
Correlation 
Coefficient -0.14 0.19 





















































































































Iron status (S/D) Ferritin (u/L) 




Coefficient 3.1/4.8 2.9/5.2 3.3/4.7 -0.36
* -0.28 -0.39 




Coefficient 11.4/12.8 12.4/13.6 10.2/12.4 -0.22 -0.06 -0.40 




Coefficient 10.9/11.4 12.0/11.8 9.4/11.2 -0.13 0.00 -0.27 




Coefficient 9.3/10.1 9.6/11.0 9.0/9.6 -0.21 -0.20 -0.27 




Coefficient 8.3/9.5 8.4/8.6 8.1/9.9 -0.21 0.01 -0.31 




Coefficient 10.0/10.1 10.4/10.0 9.6/10.2 -0.01 0.22 -0.20 
p-value 0.858 0.842 0.691 0.956 0.349 0.357 
 
S=Sufficient 
   






















































Spearman’s rho test 
CRP Faecal calprotectin 




Coefficient -0.11 -0.24 -0.01 0.10 0.02 0.10 




Coefficient -0.13 -0.33 0.06 -0.04 0.01 -0.03 




Coefficient -0.05 -0.16 0.06 -0.09 0.21 -0.20 




Coefficient -0.15 -0.19 -0.06 0.03 0.32 -0.17 




Coefficient -0.25 -0.13 -0.35 -0.16 -0.28 -0.14 




Coefficient -0.18 -0.26 -0.10 0.07 0.17 0.02 





























































BFI! Ferritin! BFI! Ferritin!
Patient'A' 4.9! 26! 2.0! 169!
Patient'B' 7.0! 11! 5.6! 206!
Patient'C' 2.7! 46! 1.7! 210!
Patient'D' 8.0! 16! 7.0! 81!
Patient'G' 6.6! 32! 3.5! 134!





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































You are invited to take part in a pilot study looking at fatigue in people who suffer 
from Inflammatory Bowel Disease, approved by the University of Otago Human 
Ethics Committee. 
 
Whether you choose or not to take part, this won’t affect the care you receive. If 
you do want to take part now, but change your mind later, you are free to pull out 
of the study at any time. 
This Participant Information Sheet sets out why we are doing the study, what 
your participation would involve, the benefits and risks, and what will happen 
when the study ends. We will go through this information with you and answer 
any questions you may have. Feel quite free to make your decision to participate 
now, or after discussion with your family, whānau, friends, or healthcare 
providers. 
 
If you agree to take part in this study, you will be asked to sign the Consent Form 
on the last page of this document. You will be given a copy of both the 
Information Sheet and the Consent Form to keep. 
 
This document is 6 pages long, including the Consent Form. Please make sure 
you have read and understood all the information provided. 
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WHAT IS THE PURPOSE OF THE STUDY? 
Fatigue is considered to be one of the main concerns for people with 
Inflammatory Bowel Disease (IBD). Yet, fatigue is poorly understood and not well 
managed. We know that it has been linked to factors including anaemia (iron 
deficiency) and the extent to which the bowel is inflamed. Most commonly, we 
measure iron levels in blood by a protein called ferritin, the body’s main indicator 
of iron stores. A low ferritin level might suggest a cause for fatigue. However, 
there is good evidence that fatigue can still be present when ferritin levels are 
above acceptable laboratory measures. There is also evidence that fatigue is 
reduced and health outcomes are improved when we increase our intake of iron. 
There are about 400 people with various forms of IBD in Dunedin and we would 
like to learn how commonly they are affected by fatigue, in the hope of 
understanding more about its management.  
 
In addition, the study aims to consider:  
The feasibility of increasing iron levels by an injection. 
The relationship between increased iron levels and fatigue. 
As this is a pilot, it will also help us to calculate the number of participants 
necessary for a future clinical study and whether we will need to recruit people 
from outside Dunedin.  
 
WHAT WILL MY PARTICIPATION IN THE STUDY INVOLVE? 
This research study will run for 6 weeks and we are looking for people with 
Inflammatory Bowel Disease. It won’t matter if you have other health issues and 
we will ensure that our research has no effect on any other treatment you might 
be receiving. 
 
You are eligible to participate in this study if you are diagnosed with Inflammatory 
Bowel Disease. The study is hoping to get an accurate representation of the 
Dunedin IBD population, so there will not be any reasons to be excluded from the 
study if you meet the eligibility requirement. 
 
After agreeing to take part, you will be asked to give a small amount of blood and 
provide stool samples from which we will measure your iron levels and the 
presence of any unidentified blood losses that might appear through your bowel. 
 
You will then be invited to answer specific questions relating to fatigue and 
complete either the Crohn’s Disease Activity Index or Simple Clinical Colitis 
Activity Index to assess your disease activity. Your blood samples will be 
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analysed for iron levels (potential anaemia), iron stores (ferritin) and a test for 
specific markers of inflammation. 
 
Your stool samples will be used to test for inflammation in your gut. According to 
those results you will then be assigned into either one of 4 groups. 
 
1) Those with active Crohn’s disease or ulcerative colitis. 
2) Non-anaemic participants without active bowel disease, with increased fatigue, 
a blood ferritin below a certain level (50µg/L) and no other medical condition that 
could account for tiredness or fatigue. 
3) Non-anaemic participants without active bowel disease or evidence of fatigue 
and a blood ferritin level above 50µg/L. 
4) Those who don’t fall into any of the above groups. 
 
If you are in group 1, 3 or 4 you will receive standard, supervised medical care. 
 
If you fall into group 2 you will be given an iron injection at the start of the study 
and another blood test 2 weeks after the injection to check if your iron levels 
have increased. Before receiving the iron injection we will make very sure that 
there is no medical reason such as allergy that would mean you could not have 
the injection. Those in Group 2 and 3 will be asked to come back in 6 weeks to 
compare their fatigue levels. 
!
!
WHAT ARE THE POSSIBLE BENEFITS AND RISKS OF THIS STUDY? 
When a blood sample is taken from one of the veins in your forearm the common 
effects are discomfort and some bruising at the site where the needle is inserted. 
However these are usually minor issues that resolve very quickly and are 
minimised by applying firm pressure over the site. 
 
Those that are in group 2 will receive the iron supplementation by direct injection 
into a vein - such as a vein found in the arm (intravenous injection).The iron 
injection will be administered in Dunedin Hospital by experienced medical and 
nursing staff in the Gastroenterology Unit. You might feel some discomfort at the 
injection site but once again this settles very quickly. The iron injection we are 
using is called Ferinject and like any substance being introduced into the body, 
carries the potential for some associated side effects. Some of these side effects 
include headache, nausea, and muscle pain. Furthermore, there is a very small 
chance of a severe allergic reaction. In the unlikely event of that or any other 
problems happening, immediate medical supervision will be available. However, 
Ferinject is widely used in medical practice and has a good safety profile. It is 
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considered to be a safe, effective and convenient injectable iron therapy. 
Ferinject (iron injection) information sheet from the New Zealand Medicines and 
Medical Devices Safety Authority will be provided. 
 
WHAT IF SOMETHING GOES WRONG? 
In the unlikely event of any injury as a direct consequence of this study, you may 
be covered by ACC. This will require the appropriate documentation process 
consistent with any ACC claim for accidental injury.  
 
If you have private health or life insurance, you may wish to check with your 
insurer that taking part in this study won’t affect your cover. 
 
CONFIDENTIALITY  
Once you have agreed to take part in this pilot study, any personal information 
held separate from your hospital notes will remain confidential and available only 
to the senior research team of doctors.  The documents you complete to 
participate in the study will identify you only by number and only the principal 
investigator will be able to match your numbered data to your name. 
 
WHAT HAPPENS AFTER THE STUDY? 
All personal identifying information will be removed from the paper records and 
electronic files which represent the data from the project, and these will be 
placed in secure storage and kept for up to ten years. 
No tissue samples will be stored during the study. All blood samples collected will 
be sent to Southern Community Laboratories to be analysed and then disposed 
of in accordance with laboratory protocols. A summary of the results from the 
study will be available, and if you wish to be informed, the research team will 
make itself available to explain these findings to you. 
 
WHO DO I CONTACT FOR MORE INFORMATION OR IF I HAVE CONCERNS? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact:  
 
Dr Hamish Osborne or Dr Michael Schultz 
Phone              03 4740999 
Email               hamish.osborne@otago.ac.nz    or   michael.schultz@otago.ac.nz 
 
If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on: 
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Phone:  0800 555 050 
Fax:   0800 2 SUPPORT (0800 2787 7678)  
Email:   advocacy@hdc.org.nz 
 











Please tick to indicate you consent to the following 
 
I have read, or have had read to me in my first language, and I 
understand the Participant Information Sheet.   Yes ! No ! 
I have been given sufficient time to consider whether or not to 
participate in this study. Yes ! No ! 
I have had the opportunity to use a legal representative, whanau/ 
family support or a friend to help me ask questions and understand 
the study. 
Yes ! No ! 
I am satisfied with the answers I have been given regarding the 
study and I have a copy of this consent form and information sheet. Yes ! No ! 
I understand that taking part in this study is voluntary (my choice) 
and that I may withdraw from the study at any time without this 
affecting my medical care. 
Yes ! No ! 
I consent to the research staff collecting and processing my 
information, including information about my health. Yes ! No ! 
I consent on receiving Ferinject (iron injection) IF I am assigned to 
the group receiving it. Yes ! No ! 
If I decide to withdraw from the study, I agree that the information 
collected about me up to the point when I withdraw may continue to 
be processed. 
Yes ! No ! 
I consent to my GP or current provider being informed about my 
participation in the study and of any significant abnormal results 
obtained during the study. 
Yes ! No ! 
I understand the nature and size of the risks of discomfort or harm 
which are explained in the Information Sheet. Yes ! No ! 
! !
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I wish to have my samples disposed of with appropriate karakia at 
the end of the study Yes ! No ! 
I consent for my samples being destroyed at the end of the study. Yes ! No ! 
I understand that my participation in this study is confidential and 
that no material, which could identify me personally, will be used in 
any reports on this study. 
Yes ! No ! 
I understand the compensation provisions in case of injury during 
the study. Yes ! No ! 
I know who to contact if I have any questions about the study in 
general. Yes ! No ! 
I understand my responsibilities as a study participant. Yes ! No ! 
I wish to receive a summary of the results from the study. Yes ! No ! 
 
 
Declaration by participant: 







Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant, and have 
answered the participant’s questions about it.   
 









1) What is your full name: _______________________________________ 
2) Are you? 
□ Male □ Female 
3) When were you born? : __ /__ /______ 
4) Which one of these statements best describes your current legally registered marital / civil union 
status? 
□ I have never been legally married and I have never 
been legally registered in a civil union 
□ I am divorced or my marriage / civil union 
has been dissolved 
□ I am a widow / widower or surviving civil union 
partner 
□ I am permanently separated from my legal 
husband / wife / civil union partner 
□ I am legally married □ I am legally registered in a civil union 
5) Which ethnic group do you belong to:  
□ New Zealand European  
□ Māori  
□ Samoan  
□ Cook Island Maori  
□ Tongan  
□ Niuean  
□ Chinese  
□ Indian  




6) Weight ___ Kg 
7) Height ___ Cm 
8) Which inflammatory bowel disease are you diagnosed with? 
□ Crohn’s disease □ Ulcerative colitis 
9) At what age were you diagnosed with IBD? ____ 
10) Do you have any family/whānau member that suffers from IBD? 
11) Are you taking any tablet/supplements not prescribed by your doctor? 
□ No  □ Yes - please specify which supplements 
 
 
12) Are you following any diet? 
□ No □ Yes – what is particular about it? 
 
 
13) Have you previously received iron supplementation (whether it’s oral or infusion)? 
□ No □ Yes 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical activities 
refer to activities that take hard physical effort and make you breathe much harder than normal.  Think 
only about those physical activities that you did for at least 10 minutes at a time. 
 
14) During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, 
digging, aerobics, or fast bicycling?   
___ Days per week 
□ No vigorous activity (skip to question 16) 
15) How much time did you usually spend doing vigorous physical activities on one of those days?  
___ Hours per day ____ Minutes per day 





Think about all the moderate activities that you did in the last 7 days.  Moderate activities refer to 
activities that take moderate physical effort and make you breathe somewhat harder than normal.  
Think only about those physical activities that you did for at least 10 minutes at a time. 
 
16) During the last 7 days, on how many days did you do moderate physical activities like carrying light 
loads, bicycling at a regular pace, or doubles tennis?  Do not include walking. 
___ Days per week 
□ No moderate activity (skip to question 18) 
17) How much time did you usually spend doing moderate physical activities on one of those days? 
___ Hours per day ____ Minutes per day 
□ Don’t know/Not sure 
 
Think about the time you spent walking in the last 7 days.  This includes at work and at home, 
walking to travel from place to place, and any other walking that you might do solely for recreation, 
sport, exercise, or leisure. 
 
18) During the last 7 days, on how many days did you walk for at least 10 minutes at a time?   
___ Days per week 
□ No walking (skip to question 20) 
 
19) How much time did you usually spend walking on one of those days?  
___ Hours per day ____ Minutes per day 
□ Don’t know/Not sure 
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  Include 
time spent at work, at home, while doing course work and during leisure time.  This may include time 
spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch television.  
 
20) During the last 7 days, how much time did you spend sitting on a week day? 






BFI - English - Formatted March 19, 2008 
 
Brief Fatigue Inventory 
STUDY ID# ____________ HOSPITAL# ____________ 
 
 
Date: ______/ ______/ ______ Time: _________________ 
Name: ___________________  ______________________  _______________ 
 Last First Middle Initial  
 Throughout our lives, most of us have times when we feel very tired or fatigued.  
Have you felt unusually tired or fatigued in the last week? Yes No 
 
1. Please rate your fatigue (weariness, tiredness) by circling the one number  
that best describes your fatigue right NOW. 
0  1  2  3  4  5  6  7  8  9  10 
No 
Fatigue 
As bad as 
you can imagine 
 
2. Please rate your fatigue (weariness, tiredness) by circling the one number that 
best describes your USUAL level of fatigue during past 24 hours. 
0  1  2  3  4  5  6  7  8  9  10 
No 
Fatigue 
As bad as 
you can imagine 
 
3. Please rate your fatigue (weariness, tiredness) by circling the one number that 
best describes your WORST level of fatigue during past 24 hours. 
0  1  2  3  4  5  6  7  8  9  10 
No 
Fatigue 
As bad as 
you can imagine 
 
4. Circle the one number that describes how, during the past 24 hours, 
fatigue has interfered with your: 
 
A. General Activity 
0  1  2  3  4  5  6  7  8  9  10 
Does not Interfere Completely Interferes 
 
B. Mood 
0  1  2  3  4  5  6  7  8  9  10 
Does not Interfere Completely Interferes 
 
C. Walking ability 
0  1  2  3  4  5  6  7  8  9  10 
Does not Interfere Completely Interferes 
 
D. Normal work (includes both work outside the home and daily chores) 
0  1  2  3  4  5  6  7  8  9  10 
Does not Interfere Completely Interferes 
 
E. Relations with other people 
0  1  2  3  4  5  6  7  8  9  10 
Does not Interfere Completely Interferes 
 
F. Enjoyment of life 
0  1  2  3  4  5  6  7  8  9  10 
Does not Interfere Completely Interferes 
 
Copyright 1999 
The University of Texas M. D. Anderson Cancer Center 








MFI MULTIDIMENSIONAL FATIGUE INVENTORY 





By means of the following statements we would like to get an idea of how you have been feeling lately. 
There is, for example, the statement: 
 "I FEEL RELAXED" 
If you think that this is entirely true, that indeed you have been feeling relaxed lately, please, place an X in 
the extreme left box; like this: 
 yes, that is true  _1 2 3 4 5 no, that is not true 
 
The more you disagree with the statement, the more you can place an X in the direction of "no, that is not 
true". Please do not miss out a statement and place only one X in a box for each statement.  
 
1 I feel fit. yes, that is true 1 2 3 4 5 no, that is not true 
2 Physically, I feel only able to do a little. yes, that is true 1 2 3 4 5 no, that is not true 
3 I feel very active. yes, that is true 1 2 3 4 5 no, that is not true 
4 I feel like doing all sorts of nice things. yes, that is true 1 2 3 4 5 no, that is not true 
5 I feel tired. yes, that is true 1 2 3 4 5 no, that is not true 
6 I think I do a lot in a day. yes, that is true 1 2 3 4 5 no, that is not true 
7 When I am doing something, I can  
keep my thoughts on it. 
yes, that is true 1 2 3 4 5 no, that is not true 
8 Physically I can take on a lot. yes, that is true 1 2 3 4 5 no, that is not true 
9 I dread having to do things. yes, that is true 1 2 3 4 5 no, that is not true 
10 I think I do very little in a day. yes, that is true 1 2 3 4 5 no, that is not true 
11 I can concentrate well. yes, that is true 1 2 3 4 5 no, that is not true 
12 I am rested. yes, that is true 1 2 3 4 5 no, that is not true 
13 It takes a lot of effort to concentrate  
on things. 
yes, that is true 1 2 3 4 5 no, that is not true 
14 Physically I feel I am in a bad condition. yes, that is true 1 2 3 4 5 no, that is not true 
15 I have a lot of plans. yes, that is true 1 2 3 4 5 no, that is not true 
16 I tire easily. yes, that is true 1 2 3 4 5 no, that is not true 
17 I get little done. yes, that is true 1 2 3 4 5 no, that is not true 
18 I don't feel like doing anything. yes, that is true 1 2 3 4 5 no, that is not true 
19 My thoughts easily wander. yes, that is true 1 2 3 4 5 no, that is not true 
20 Physically I feel I am in an excellent 
condition. 
yes, that is true 1 2 3 4 5 no, that is not true 
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The Simple Clinical Colitis Activity Index (SCCAI) uses a set of questions to give a 
good overall view of the activity of the disease in patients with UC. It is used 
internationally to aid patients and doctors in monitoring and assessing UC activity. 
 
The SCCAI is traditionally completed by the treating specialist doctor, but this leaflet 
is designed to teach you how to score your own SCCAI. That will allow you to tell 
the people looking after you exactly how active your disease is, and allow you and 
your doctor to decide on the best treatment. 
 
 
This next section takes you through the 5 questions that make up the Simple Clinical 
Colitis Activity Index. 
Answer according to the symptoms you have over the past 3 days. 
 
1. (a) Number of bowel motions passed during the daytime, i.e. from waking up till 
going to bed to sleep. 
     1-3 times      0 points 
   4-6 times      1 point 
   7-9 times      2 points 
   > 9 times      3 points 
 
1. (b) Number of bowel motions passed during night time, i.e. After going to bed. 
   1-3 times      1 point 
   4-6 times      2 points 
 
2. Urgency of defecation.  
 i.e. When you feel the need to open your bowels, how urgently do you need to do so? 
            had no urgency at all (i.e. just as normal)    0 points 
 had to hurry to the toilet      1 point 
had to go immediately       2 points          
incontinence (been unable to control the urge and had an accident) 
          3 points 
 
3. How much blood has been in your stool? 
 None         0 Point 
 Trace – (a hint or a tiny amount)     1 point 
 Moderate (occasional obvious/frank blood)    2 points 
    Severe (Usually obvious/frank blood)     3 points  
 
4. General well being – How do you feel about your general health? 
 Very well         0 point 
 Slightly below par (a little unwell)      1 point 
 Poor          2 points 
 Very poor         3 points 





5. Extra colonic features (other related symptoms apart form your bowels) 
 
(a). Joint problems; have you had painful, red or swollen joints?  
The most common joints affected are the knees, ankles or toes.  
           1 point 
 
(b). Eye problems; have you had sore, red and swollen eyes?.    
 Other symptoms include blurry vision, sensitivity to light, floaters and increased tear 
production. 
  1 point  
 
Note:  If you have a painful red eye or if you have been diagnosed with uveitis, 
episcleritis or scleritis and recognize a flare of your symptoms. Seek medical help 
urgently. 
 
(c). Mouth problems; The most common problem are round or oval mouth ulcers 
(Apthous Ulcers). These are usually painful, round yellowish elevated spots 
surrounded by a red halo.       
 
  1 point 
   
(d). Skin problems:   
Deep, purple ulcers, often painful, usually developing suddenly (known as Pyoderma 
gangrenosum)        
  1 point 
 
Tender, hot and red bumps mainly affects the skin of shins, arms and legs (known as 
Erythema nodosum).  
  1 point 
 
Problems around the anus. 
Anal fissures/ abscess (boil), - Tear or breakdown (crack/ cleft) in the skin of the anus 
or surrounding it.          
  1 point 
  
• Your Total Score :       _____ 
 
